About De Harbien Life Sciences Private Limited
Data last updated:
De Harbien Life Sciences Private Limited is a private limited company based in Thiruvananthapuram, Kerala, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 November 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U51397KL2016PTC047177. Its GSTIN is 32AAFCD9001N1ZP (Kerala).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Janardhanannair Harish and Salini Parukuttyamma Sivankuttynair.
Its last annual general meeting (AGM) was held on 11 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thiruvananthapuram, Kerala.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.8 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹48.33 Lakh (net margin 8.3%) and EBITDA of ₹99.53 Lakh (EBITDA margin 17.2%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 14% over five years.
As per MCA filings, the company has open charges of ₹2.56 Cr on record. Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website derenon.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressDera – 28 Harsham Tc 85/921 And 921(1), Palkulangara Devi Temple East Nada Pettah P.O, Thiruvananthapuram, Kerala, India – 695024
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of De Harbien Life Sciences Private Limited
The main business activity of De Harbien Life Sciences is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of De Harbien Life Sciences Private Limited FY 2025 filings available
De Harbien Life Sciences Private Limited reported revenue of ₹5.8 Cr (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of De Harbien Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 9% growth in the latest year. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of De Harbien Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹99.53 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹48.33 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of De Harbien Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 8.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of De Harbien Life Sciences are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of De Harbien Life Sciences Private Limited
De Harbien Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sanjivani Biocare Private Limited | ₹5.82 Cr (FY 2025) | •••• | •••• | 2900.0% | •••• | Pune, Maharashtra, India |
| Awake Medicare Private Limited | ₹5.81 Cr (FY 2025) | •••• | •••• | -31.0% | •••• | Lucknow, Uttar Pradesh, India |
| Aquinnova Healthcare Private Limited | ₹5.81 Cr (FY 2024) | •••• | •••• | 25.0% | •••• | Bhiwandi, Maharashtra, India |
| Maryus Healthcare Private Limited | ₹5.81 Cr (FY 2025) | •••• | •••• | -36.0% | •••• | Mumbai, Maharashtra, India |
| Next Gen Pharma India Private Limited | ₹5.8 Cr (FY 2023) | •••• | •••• | -30.0% | •••• | Delhi, India |
| De Harbien Life Sciences Private Limited this company | ₹5.8 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Thiruvananthapuram, Kerala, India |
| Soul Medicare Private Limited | ₹5.8 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Bikaner, Rajasthan, India |
| Sundaram Pharma Private Limited | ₹5.79 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Mumbai, Maharashtra, India |
| Biorow Life Sciences Limited | ₹5.78 Cr (FY 2021) | •••• | •••• | 1.0% | •••• | Bangalore, Karnataka, India |
| Ralli's Therapeutics Private Limited | ₹5.78 Cr (FY 2024) | •••• | •••• | -28.0% | •••• | Delhi, India |
| Dixit Distributors Private Limited | ₹5.77 Cr (FY 2025) | •••• | •••• | -17.0% | •••• | Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below De Harbien Life Sciences by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of De Harbien Life Sciences Private Limited
De Harbien Life Sciences Private Limited is audited by J K V & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| J K V & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of De Harbien Life Sciences Private Limited
De Harbien Life Sciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Janardhanannair Harish | Director | 02 Nov 2016 | 9 Years 11 Months | Current |
| Salini Parukuttyamma Sivankuttynair | Director | 02 Nov 2016 | 9 Years 11 Months | Current |
Ownership and Shareholding of De Harbien Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of De Harbien Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 May 2025 | Hdfc Bank Limited | ₹60.06 Lakh | Open |
| 28 Aug 2024 | Hdfc Bank Limited | ₹10.01 Lakh | Open |
| 30 Oct 2023 | Hdfc Bank Limited | ₹36 Lakh | Open |
| 30 Nov 2022 | Others | ₹1 Cr | Open |
| 25 Jul 2022 | Hdfc Bank Limited | ₹49.5 Lakh | Open |
Total charge records: 5 View all charges
Legal Cases of De Harbien Life Sciences Private Limited
De Harbien Life Sciences Private Limited has 2 court cases on record: 2 filed against it. 1 case is pending and 1 is disposed. Status as checked on 21 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Mankind Pharma Limited | Pending |
| High Court of Delhi | Commercial suit | Filed against the company by La Renon Healthcare Private Limited | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at De Harbien Life Sciences Private Limited
Employment history and EPFO contributions of people linked to De Harbien Life Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on De Harbien Life Sciences Private Limited
De Harbien Life Sciences Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Janardhanannair Harish was appointed as Director on 02 Nov 2016.
Credit Ratings, Litigation & Regulatory Alerts for De Harbien Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by De Harbien Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of De Harbien Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of De Harbien Life Sciences Private Limited
De Harbien Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAFCD9001N1ZP | Kerala | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of De Harbien Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about De Harbien Life Sciences Private Limited
De Harbien Life Sciences is an active private limited company based in Thiruvananthapuram, Kerala, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 November 2016 (10+ years old) and is registered under CIN U51397KL2016PTC047177.
De Harbien Life Sciences reported revenue of ₹5.8 Cr for FY 2025 (up 9% YoY).
De Harbien Life Sciences has 2 current directors:
- Janardhanannair Harish - Director
- Salini Parukuttyamma Sivankuttynair - Director
De Harbien Life Sciences reported a net profit of ₹48.33 Lakh (net margin 8.3%) and EBITDA of ₹99.53 Lakh (EBITDA margin 17.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of De Harbien Life Sciences is 18% over three years and 14% over five years. In the latest year (FY 2025) revenue rose 9%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of De Harbien Life Sciences is 32AAFCD9001N1ZP, registered in Kerala.
The CIN (Corporate Identification Number) of De Harbien Life Sciences is U51397KL2016PTC047177. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
De Harbien Life Sciences has 2 court cases on record: 2 filed against it. 1 is pending.
De Harbien Life Sciences was incorporated on 02 November 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of De Harbien Life Sciences by revenue are Sanjivani Biocare Private Limited, Awake Medicare Private Limited, Aquinnova Healthcare Private Limited, Maryus Healthcare Private Limited, Next Gen Pharma India Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Janardhanannair Harish was appointed as Director on 02 Nov 2016. Salini Parukuttyamma Sivankuttynair was appointed as Director on 02 Nov 2016.